Aktuellt
SENASTE
Redeye provides an update following SenzaGen’s Q4 2024 report. The sales during the quarter were disappointing, although we maintain that the long-term investment case remains intact. We have made sales estimate adjustments, which is the main reason for our lowered fair value range.
LÄS MER
